The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Clorox Co

NYSE: CLX
Last

(U.S.) $103.82

Today's change+1.82 +1.78%
Updated December 18 4:01 PM EST. Delayed by at least 15 minutes.
 

Clorox Co

NYSE: CLX
Last

(U.S.) $103.82

Today's change+1.82 +1.78%
Updated December 18 4:01 PM EST. Delayed by at least 15 minutes.

Clorox Co Hits New 52-week High

Clorox Co closed up sharply Thursday, rallying (U.S.)$1.82 or 1.78% to (U.S.)$103.82 and setting a new 52-week high. Over the last five days, shares have gained 2.87% and 11.92% year to date. Shares have underperformed the S&P 500 by 2.68% during the last year.

Key company metrics

  • Open(U.S.) $102.80
  • Previous close(U.S.) $102.00
  • High(U.S.) $103.83
  • Low(U.S.) $102.12
  • Bid / Ask-- / --
  • YTD % change+11.92%
  • Volume1,040,808
  • Average volume (10-day)1,112,588
  • Average volume (1-month)1,218,525
  • Average volume (3-month)1,287,091
  • 52-week range(U.S.) $83.70 to (U.S.) $103.83
  • Beta0.44
  • Trailing P/E23.96×
  • P/E 1 year forward22.90×
  • Forward PEG4.16×
  • Indicated annual dividend(U.S.) $2.96
  • Dividend yield2.85%
  • Trailing EPS(U.S.) $4.33
Updated December 18 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.22%

Based on its net profit margin of 10.22%, Clorox Co is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.93%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Household Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014Dec 31, 201312/31/2013
Revenue1,3521,5111,3861,330
Total other revenue--------
Total revenue1,3521,5111,3861,330
Gross profit578639579557
Total cost of revenue774872807773
Total operating expense1,1341,2531,1721,149
Selling / general / administrative301326302323
Research & development30352831
Depreciation / amortization--------
Interest expense (income), net operating27272627
Unusual expense (income)--------
Other operating expenses, total3-610-4
Operating income218258214181
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax218258214181
Income after tax145170139116
Income tax, total73887565
Net income90170137115
Total adjustments to net income--------
Net income before extra. items145170139116
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items145170139116
Inc. avail. to common incl. extra. items90170137115
Diluted net income90170137115
Dilution adjustment--------
Diluted weighted average shares131131132132
Diluted EPS excluding extraordinary itemsvalue per share1.101.301.060.88
Dividends per sharevalue per share0.740.740.710.71
Diluted normalized EPSvalue per share1.101.301.060.88